Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 69.23B | 69.42B | 71.05B | 64.33B | 56.95B | 54.62B |
Gross Profit | 8.76B | 9.13B | 8.68B | 8.09B | 7.12B | 6.77B |
EBITDA | 1.31B | 2.96B | 2.58B | 971.00M | 483.00M | 164.00M |
Net Income | 1.62B | 1.78B | 1.53B | 650.00M | 261.00M | 398.00M |
Balance Sheet | ||||||
Total Assets | 47.14B | 45.82B | 48.42B | 45.47B | 41.65B | 44.56B |
Cash, Cash Equivalents and Short-Term Investments | 6.34B | 6.54B | 6.39B | 4.36B | 4.42B | 6.07B |
Total Debt | 3.87B | 3.76B | 4.63B | 4.36B | 4.44B | 4.29B |
Total Liabilities | 26.06B | 24.28B | 27.42B | 26.15B | 23.56B | 24.37B |
Stockholders Equity | 20.92B | 21.37B | 20.85B | 19.16B | 17.96B | 20.08B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 471.00M | 1.63B | 224.00M | -1.58B | 1.32B |
Operating Cash Flow | 0.00 | 624.00M | 1.92B | 563.00M | -1.18B | 1.68B |
Investing Cash Flow | 0.00 | 1.04B | 178.00M | -319.00M | -338.00M | 164.00M |
Financing Cash Flow | 0.00 | -1.57B | -121.00M | -332.00M | -205.00M | -238.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥10.44B | 12.35 | 2.60% | 19.85% | 78.11% | ||
74 Outperform | ¥9.21B | 8.78 | 0.38% | 19.52% | -9.23% | ||
73 Outperform | ¥7.69B | 10.75 | 4.54% | 0.83% | -20.99% | ||
73 Outperform | ¥9.56B | 5.39 | 3.74% | -2.30% | 16.63% | ||
71 Outperform | ¥8.05B | 19.38 | 4.33% | -3.80% | -9.74% | ||
71 Outperform | ¥11.57B | 11.60 | 3.18% | 4.00% | -15.26% | ||
58 Neutral | HK$13.95B | 4.43 | -3.01% | 7.31% | 3.67% | -54.16% |